Author Index

Search or browse for an author across our entire electronic archive

Search results for: R
Results 211 - 220 of 1271 shown below

  • Rastogi, S

    A V Timoshenko, S Rastogi and P K Lala

    Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells

    advance online publication, 2007-10-02 00:00:00.000;

    doi:10.1038/sj.bjc.6603993

  • Rasul, S

    S Rasul, R Balasubramanian, A Filipovic acute, M J Slade, E Yagüe and R C Coombes

    Inhibition of italic gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells

    doi:10.1038/sj.bjc.6605034

  • Ratain, M J

    B C Goh, E E Vokes, A Joshi and M J Ratain

    Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours

    doi:10.1038/sj.bjc.6600123

  • T Eisen, T Ahmad, K T Flaherty, M Gore, S Kaye, R Marais, I Gibbens, S Hackett, M James, L M Schuchter, K L Nathanson, C Xia, R Simantov, B Schwartz, M Poulin-Costello, P J O'Dwyer and M J Ratain

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    advance online publication, 2006-08-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603291

  • P H O'Donnell and M J Ratain

    Evaluating the activity of temsirolimus in neuroendocrine cancer

    advance online publication, 2006-12-12 00:00:00.000;

    doi:10.1038/sj.bjc.6603513

  • Ratanatharathorn, V

    Z Guan, Y Wang, S Maoleekoonpairoj, Z Chen, W S Kim, V Ratanatharathorn, W H H Reece, T W Kim and M Lehnert

    Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma

    doi:10.1038/sj.bjc.6601369

  • S Li, E Hanna, R Breau, V Ratanatharathorn, X Xia and J Suen

    Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs

    doi:10.1038/sj.bjc.6601636

  • Ratashak, A

    H K Roy, W J Karoski, A Ratashak and T C Smyrk

    Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation

    doi:10.1054/bjoc.2001.1807

  • Ratcliffe, C

    E Passalidou, M Trivella, N Singh, M Ferguson, J Hu, A Cesario, P Granone, A G Nicholson, P Goldstraw, C Ratcliffe, M Tetlow, I Leigh, A L Harris, K C Gatter and F Pezzella

    Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas

    doi:10.1038/sj.bjc.6600015

  • Ratcliffe, D

    L Fallowfield, D Ratcliffe, V Jenkins and J Saul

    Psychiatric morbidity and its recognition by doctors in patients with cancer

    doi:10.1054/bjoc.2001.1724

  • Ratcliffe, P

    P H Watson, S K Chia, C C Wykoff, C Han, R D Leek, W S Sly, K C Gatter, P Ratcliffe and A L Harris

    Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma

    doi:10.1038/sj.bjc.6600796

  • Ratcliffe, P J

    K J Turner, J P Crew, C C Wykoff, P H Watson, R Poulsom, J Pastorek, P J Ratcliffe, D Cranston and A L Harris

    The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer

    doi:10.1038/sj.bjc.6600215

  • C C Wykoff, C Sotiriou, M E Cockman, P J Ratcliffe, P Maxwell, E Liu and A L Harris

    Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene

    doi:10.1038/sj.bjc.6601567

  • C C Wykoff, C Sotiriou, M E Cockman, P J Ratcliffe, P Maxwell, E Liu and A L Harris

    Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene

    advance online publication, 2004-02-24 00:00:00.000;

    doi:10.1038/sj.bjc.6601657

  • K W Lau, Y-M Tian, R R Raval, P J Ratcliffe and C W Pugh

    Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms

    advance online publication, 2007-03-27 00:00:00.000;

    doi:10.1038/sj.bjc.6603675

  • Ratcliffe, W A

    J Walls, A Assiri, A Howell, E Rogers, W A Ratcliffe, R Eastell and N J Bundred

    Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases

    doi:10.1038/sj.bjc.6690496